Neonatal Genetic Screening Results for Spinal Muscular Atrophy in Romania: Insights from a 3-Years Pilot Program
Identification
- Clé publique
- radar:r-83c9acc00ddefe913975e1d6eb95bbb1
- Auteurs
- Mădălina Cristina Leanca · Gelu Onose · Georgiana Nicolae · Elena Neagu · Daniela Vasile · Ecaterina Bercu · Oana Mirabela Balanescu · Andrei Căpitănescu · Constantin Munteanu · C. Popescu · Andrada Mirea
- Année déclarée
- 2026
- Langue déclarée
- en
- Type source
- article
- Première détection
- 2026-11-13T12:44:36.165909+00:00
- Dernière observation des métadonnées
- 2026-11-13T12:44:36.165909+00:00
- Dernière vérification HTTP
- Non effectuée
Institutions déclarées par la source
Carol Davila University of Medicine and Pharmacy · Spitalului Clinic de Urgență pentru Copii Maria Sklodowska Curie · Grigore T. Popa University of Medicine and Pharmacy
Pays d’affiliation déclarés
RO
Résumé documentaire — langue originale
Spinal muscular atrophy (SMA) is a severe genetic neuromuscular disorder caused by bi-allelic deletions or pathogenic SMN1 variants. Early diagnosis through neonatal screening is essential for timely therapeutic intervention, significantly improving clinical outcomes. In August 2022, a pilot neonatal screening program for SMA was launched in Romania, aiming to assess feasibility and impact. Objectives are to present the preliminary results of the ongoing SMA neonatal screening pilot program in Romania, evaluating its effectiveness in early detection and referral for treatment. The program started in August 2022 with four maternity hospitals and has progressively expanded to 28 maternity hospitals nationwide. Dried blood spot samples from newborns were analyzed for SMN1 gene deletions using real-time PCR. Positive results were confirmed through genetic testing, and affected infants, along with their families, were referred for further medical evaluation and early therapeutic intervention. Approximately 60,000 newborns have been screened since the program’s inception, and 12 newborns tested positive for SMN1 deletions, resulting in an estimated incidence rate of 1 in 5125 live births. All confirmed cases were promptly referred for specialized care, with early access to disease-modifying therapies. The program has faced challenges in logistics, parental awareness, and equitable access to treatment, but its expansion from 4 to 28 maternities demonstrates increasing feasibility, suitability, and acceptance. Conclusions: The Romanian pilot neonatal screening program for SMA has successfully identified affected infants early, proving its feasibility and clinical impact. The ongoing expansion suggests a strong foundation for a future national program, which could significantly improve early SMA diagnosis and patient outcomes in Romania.
Identifiants
- OPENALEX
- https://openalex.org/W7127181044
- DOI
- 10.3390/ijns12010006
- PMID
- https://pubmed.ncbi.nlm.nih.gov/41718420
- PMCID
- https://www.ncbi.nlm.nih.gov/pmc/articles/12957999
Repères documentaires
- Famille documentaire
- article
- Types déclarés par les sources
- article
- Éditeurs
- Multidisciplinary Digital Publishing Institute
Les mentions d’entités ne constituent pas une preuve de reconnaissance juridique. La juridiction étudiée est distincte du pays d’affiliation des auteurs.
Sources
OpenAlex · Document 1
Citer cette référence
Mădălina Cristina Leanca; Gelu Onose; Georgiana Nicolae; Elena Neagu; Daniela Vasile; Ecaterina Bercu; Oana Mirabela Balanescu; Andrei Căpitănescu; Constantin Munteanu; C. Popescu; Andrada Mirea. Neonatal Genetic Screening Results for Spinal Muscular Atrophy in Romania: Insights from a 3-Years Pilot Program. 2026. https://doi.org/10.3390/ijns12010006
JSON · CSL-JSON · BibTeX · RIS · CSV · JSON-LD ·
APA, Chicago, ISO 690 : formats bibliographiques fondés sur les champs disponibles. OSCOLA / Bluebook : données structurées uniquement ; aucune conformité juridique complète n’est revendiquée sans vérification des éléments nécessaires.
- APA
- Mădălina Cristina Leanca; Gelu Onose; Georgiana Nicolae; Elena Neagu; Daniela Vasile; Ecaterina Bercu; Oana Mirabela Balanescu; Andrei Căpitănescu; Constantin Munteanu; C. Popescu; Andrada Mirea. (2026). Neonatal Genetic Screening Results for Spinal Muscular Atrophy in Romania: Insights from a 3-Years Pilot Program. https://doi.org/10.3390/ijns12010006
- Chicago
- Mădălina Cristina Leanca; Gelu Onose; Georgiana Nicolae; Elena Neagu; Daniela Vasile; Ecaterina Bercu; Oana Mirabela Balanescu; Andrei Căpitănescu; Constantin Munteanu; C. Popescu; Andrada Mirea. Neonatal Genetic Screening Results for Spinal Muscular Atrophy in Romania: Insights from a 3-Years Pilot Program. 2026. https://doi.org/10.3390/ijns12010006
- ISO 690
- Mădălina Cristina Leanca; Gelu Onose; Georgiana Nicolae; Elena Neagu; Daniela Vasile; Ecaterina Bercu; Oana Mirabela Balanescu; Andrei Căpitănescu; Constantin Munteanu; C. Popescu; Andrada Mirea. Neonatal Genetic Screening Results for Spinal Muscular Atrophy in Romania: Insights from a 3-Years Pilot Program. 2026. https://doi.org/10.3390/ijns12010006
Warning: Undefined array key "last_link_verified" in /home/clients/e27d81e12f04d2bfd747aa264540ac56/sites/_UDTR_APP/legal_library_reference.php on line 31
UDTR — Bibliothèque juridique mondiale des droits de la Nature. Neonatal Genetic Screening Results for Spinal Muscular Atrophy in Romania: Insights from a 3-Years Pilot Program. Notice documentaire: https://www.declarationuniverselledesdroitsdelarbre.org/global-rights-of-nature-radar/reference/r-83c9acc00ddefe913975e1d6eb95bbb1/ · Dernière vérification HTTP : non effectuée
Données de cette version figée
Dossiers et relations documentaires
Rôles des sources
Source bibliographique / publication d’origine · https://doi.org/10.3390/ijns12010006
Un lien vers une autorité ne prouve pas à lui seul une affirmation juridique. Les résumés et les textes intégraux restent soumis aux conditions de leur source.
Statut documentaire
Pertinence à examiner
Bibliothèque
Cette identité n’est pas encore intégrée à la Bibliothèque juridique.